Literature DB >> 20216213

MicroRNAs in erythropoiesis.

Guowei Zhao1, Duonan Yu, Mitchell J Weiss.   

Abstract

PURPOSE OF REVIEW: MicroRNAs (miRNAs) are small, noncoding RNAs that regulate protein synthesis posttranscriptionally. Although they were discovered only about 15 years ago, it is now clear that miRNAs participate in the formation and function of virtually all vertebrate tissues. Moreover, dysregulation of miRNAs contributes to numerous diseases, including cancer. Here, we review the field of miRNA biology, emphasizing its impact on erythropoiesis. RECENT
FINDINGS: Genetic disruption of global miRNA synthesis in hematopoietic tissues causes anemia with blocked erythropoiesis. Current research focuses on identifying specific miRNAs and associated genetic pathways that modulate normal and pathological erythroid development. In parallel, new technologies to examine and manipulate miRNAs, both as research tools and as therapeutic targets, are emerging rapidly.
SUMMARY: The field of miRNA biology is evolving and expanding at a remarkable pace. Continued research into how miRNAs impact erythropoiesis will advance our basic understanding of this process and perhaps provide new insights into diagnosing and treating erythrocyte disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20216213     DOI: 10.1097/MOH.0b013e328337ba6c

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  23 in total

1.  miR-191 regulates mouse erythroblast enucleation by down-regulating Riok3 and Mxi1.

Authors:  Lingbo Zhang; Johan Flygare; Piu Wong; Bing Lim; Harvey F Lodish
Journal:  Genes Dev       Date:  2010-12-31       Impact factor: 11.361

Review 2.  Peripheral blood microRNAs: A novel tool for diagnosing disease?

Authors:  Ziqiang Wang; Yanqin Lu; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2012-08

3.  Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3zeta.

Authors:  David M Patrick; Cheng C Zhang; Ye Tao; Huiyu Yao; Xiaoxia Qi; Robert J Schwartz; Lily Jun-Shen Huang; Eric N Olson
Journal:  Genes Dev       Date:  2010-08-01       Impact factor: 11.361

4.  MIR144 and MIR451 regulate human erythropoiesis via RAB14.

Authors:  MinJung Kim; Yee Sun Tan; Wen-Chih Cheng; Tami J Kingsbury; Shelly Heimfeld; Curt I Civin
Journal:  Br J Haematol       Date:  2014-10-14       Impact factor: 6.998

5.  MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13.

Authors:  Vijay G Sankaran; Tobias F Menne; Danilo Šćepanović; Jo-Anne Vergilio; Peng Ji; Jinkuk Kim; Prathapan Thiru; Stuart H Orkin; Eric S Lander; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-04       Impact factor: 11.205

6.  Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia.

Authors:  Aisha L Walker; Shirley Steward; Thad A Howard; Nicole Mortier; Matthew Smeltzer; Yong-Dong Wang; Russell E Ware
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

Review 7.  MicroRNAs in erythroid and megakaryocytic differentiation and megakaryocyte-erythroid progenitor lineage commitment.

Authors:  L Zhang; V G Sankaran; H F Lodish
Journal:  Leukemia       Date:  2012-05-23       Impact factor: 11.528

8.  Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation.

Authors:  Wenqian Hu; Bingbing Yuan; Johan Flygare; Harvey F Lodish
Journal:  Genes Dev       Date:  2011-12-08       Impact factor: 11.361

9.  miR-451 regulates FoxO3 nuclear accumulation through Ywhaz in human colorectal cancer.

Authors:  Yaoyao Li; Jijun Wang; Xiaorong Dai; Zhengbin Zhou; Jing Liu; Yu Zhang; Yan Li; Yaying Hou; Lei Pang; Xiaohong Wang; Chenhai Wang; Zhenfeng Hao; Yanqing Zhang; Jixin Jiang; Hongwei Cheng; Duonan Yu
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

10.  Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum.

Authors:  Gregory LaMonte; Katelyn A Walzer; Joshua Lacsina; Christopher Nicchitta; Jen-Tsan Chi
Journal:  J Vis Exp       Date:  2015-12-04       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.